Clinical Study

Performance of a New HPV Cervi-Collect Collection and Transportation Kit

Table 1

Agreement between Cervi-Collect and PreservCyt L-Pap specimens tested by the Abbott RealTime HR HPV assay.

Abbott RealTime HR HPV with Cervi-Collect
+

Abbott RealTime HR HPV with PreservCyt L-Pap+848
6105

Positive agreement—85.7% (84/98); Negative agreement—88.2% (105/119); Overall agreement—93.1% (189/203) (kappa = 0.86).